Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Exercise/Conversion of 15,325 CCCC shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | C4 Therapeutics, Inc. (CCCC) | Exercise/Conversion | 15,325 | n/a |
| Feb 18, 2026 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 240,000 | n/a |
| Jan 16, 2026 | C4 Therapeutics, Inc. (CCCC) | Sale | 10,000 | $22.2K |
| Jul 14, 2025 | C4 Therapeutics, Inc. (CCCC) | Tax Withholding | 7,382 | $14.7K |
| Feb 18, 2025 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 87,100 | n/a |
| Jul 11, 2024 | C4 Therapeutics, Inc. (CCCC) | Tax Withholding | 6,191 | $31.0K |
| Feb 15, 2024 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 36,700 | n/a |
| Jul 12, 2023 | C4 Therapeutics, Inc. (CCCC) | Grant/Award | 61,300 | n/a |